-
Clinical Proteomic Tumor Analysis Consortium Data
- Alternate Title(s)
- CPTAC
- Description
The Clinical Proteomic Tumor Analysis Consortium (CPTAC) analyzes cancer biospecimens by mass spectrometry, characterizing and quantifying their constituent proteins, or proteome. Proteomic analysis for each CPTAC study is carried out independently by Proteomic Characterization Centers (PCCs) using a variety of protein fractionation techniques, instrumentation, and workflows. Mass spectrometry and...
- Subject
-
CancerGenomics
- Access Rights
- Free to All
-
Proteomics analyses of dexamethasone-treated PB and CB erythroid progenitors
Internal Dataset- Authors
- Ryan AshleyHongxia YanNan WangJohn Hale14 more author(s)...
- Description
Biological triplicates of peripheral blood (PB)- and cord blood (CB)-derived colony-forming unit-erythroids (CFU-Es) were treated in the absence or presence of dexamethasone (100 nM) for 24 hours. These cells were then processed for proteomics analysis by liquid chromatography–tandem mass spectrometry (LC-MS/MS). Proteomics quantified 10,045 proteins in PB samples and 10,028 proteins in CB samples....
- Subject
-
AnemiaChronic DiseaseDrug Resistance
- Access Rights
- Free to All
- Local Expert
- Adrianna VlachosJeffrey LiptonLionel Blanc
Filter by
Subject Domain
- Anemia 1
- Cancer 1
- Chronic Disease 1
- Drug Resistance 1
- Genomics 1